These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 31960441

  • 1. A Prognostic Strategy Based on Stage of Cirrhosis and HVPG to Improve Risk Stratification After Variceal Bleeding.
    La Mura V, Garcia-Guix M, Berzigotti A, Abraldes JG, García-Pagán JC, Villanueva C, Bosch J.
    Hepatology; 2020 Oct; 72(4):1353-1365. PubMed ID: 31960441
    [Abstract] [Full Text] [Related]

  • 2. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
    Sauerbruch T, Mengel M, Dollinger M, Zipprich A, Rössle M, Panther E, Wiest R, Caca K, Hoffmeister A, Lutz H, Schoo R, Lorenzen H, Trebicka J, Appenrodt B, Schepke M, Fimmers R, German Study Group for Prophylaxis of Variceal Rebleeding.
    Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
    [Abstract] [Full Text] [Related]

  • 3. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial.
    Mishra SR, Chander Sharma B, Kumar A, Sarin SK.
    Gut; 2010 Jun; 59(6):729-35. PubMed ID: 20551457
    [Abstract] [Full Text] [Related]

  • 4. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C, Aracil C, Colomo A, Hernández-Gea V, López-Balaguer JM, Alvarez-Urturi C, Torras X, Balanzó J, Guarner C.
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [Abstract] [Full Text] [Related]

  • 5. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J, Portal Hypertension Collaborative Group.
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [Abstract] [Full Text] [Related]

  • 6. Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes.
    Garcia-Guix M, Ardevol A, Sapena V, Alvarado-Tápias E, Huertas A, Brujats A, Fajardo J, Cuyas B, Poca M, Guarner C, Torras X, Escorsell À, Villanueva C.
    Liver Int; 2024 Aug; 44(8):1971-1989. PubMed ID: 38634685
    [Abstract] [Full Text] [Related]

  • 7. Correlation of HVPG level with ctp score, MELD Score, ascites, size of varices, and etiology in cirrhotic patients.
    Ramanathan S, Khandelwal N, Kalra N, Bhatia A, Dhiman RK, Duseja AK, Chawla YK.
    Saudi J Gastroenterol; 2016 Aug; 22(2):109-15. PubMed ID: 26997216
    [Abstract] [Full Text] [Related]

  • 8. Long-term follow-up of hemodynamic responders to pharmacological therapy after variceal bleeding.
    Augustin S, González A, Badia L, Millán L, Gelabert A, Romero A, Segarra A, Martell M, Esteban R, Guardia J, Genescà J.
    Hepatology; 2012 Aug; 56(2):706-14. PubMed ID: 22378235
    [Abstract] [Full Text] [Related]

  • 9. Correlation of hepatic venous pressure gradient with variceal bleeding, size of esophageal varices, etiology, ascites and degree of liver dysfunction in cirrhosis of liver.
    Gulzar GM, Zargar SA, Jalal S, Alaie MS, Javid G, Suri PK, Shah NA, Bilal-Ul-Rehman, Hakeem MS, Shoukat A, Dar GA.
    Indian J Gastroenterol; 2009 Aug; 28(2):59-61. PubMed ID: 19696990
    [Abstract] [Full Text] [Related]

  • 10. Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics.
    Tey TT, Gogna A, Irani FG, Too CW, Lo HG, Tan BS, Tay KH, Lui HF, Chang PE.
    Singapore Med J; 2016 Mar; 57(3):132-7. PubMed ID: 26996384
    [Abstract] [Full Text] [Related]

  • 11. Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy.
    Villanueva C, Aracil C, Colomo A, Lopez-Balaguer JM, Piqueras M, Gonzalez B, Torras X, Guarner C, Balanzo J.
    Aliment Pharmacol Ther; 2009 Feb 15; 29(4):397-408. PubMed ID: 19006538
    [Abstract] [Full Text] [Related]

  • 12. Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis.
    Stanley AJ, Robinson I, Forrest EH, Jones AL, Hayes PC.
    QJM; 1998 Jan 15; 91(1):19-25. PubMed ID: 9519209
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension.
    Escorsell A, Bordas JM, Castañeda B, Llach J, García-Pagán JC, Rodés J, Bosch J.
    Hepatology; 2000 May 15; 31(5):1061-7. PubMed ID: 10796880
    [Abstract] [Full Text] [Related]

  • 14. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY, Baik SK, Suk KT, Yea CJ, Lee IY, Kim JW, Cha SH, Kim YJ, Um SH, Han KH.
    Korean J Hepatol; 2008 Jun 15; 14(2):150-8. PubMed ID: 18617762
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study.
    González A, Augustin S, Pérez M, Dot J, Saperas E, Tomasello A, Segarra A, Armengol JR, Malagelada JR, Esteban R, Guardia J, Genescà J.
    Hepatology; 2006 Oct 15; 44(4):806-12. PubMed ID: 17006916
    [Abstract] [Full Text] [Related]

  • 16. Increase in Free Hepatic Venous Pressure Response to Beta-Blockers Predicts Variceal Bleeding in Cirrhotic Patients.
    Guo H, Xiao J, Wang Y, Zhang M, Zhuge Y, Zhang F.
    Biomed Res Int; 2021 Oct 15; 2021():5587566. PubMed ID: 33997022
    [Abstract] [Full Text] [Related]

  • 17. Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status.
    Wadhawan M, Dubey S, Sharma BC, Sarin SK, Sarin SK.
    Dig Dis Sci; 2006 Dec 15; 51(12):2264-9. PubMed ID: 17080245
    [Abstract] [Full Text] [Related]

  • 18. Role of hepatic hemodynamic study in the evaluation of patients with cirrhosis.
    Dittrich S, de Mattos AA, Becker M, Gonçaves DM, Cheinquer H.
    Hepatogastroenterology; 2003 Dec 15; 50(54):2052-6. PubMed ID: 14700005
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
    Villanueva C, Graupera I, Aracil C, Alvarado E, Miñana J, Puente Á, Hernandez-Gea V, Ardevol A, Pavel O, Colomo A, Concepción M, Poca M, Torras X, Reñe JM, Guarner C.
    Hepatology; 2017 May 15; 65(5):1693-1707. PubMed ID: 28100019
    [Abstract] [Full Text] [Related]

  • 20. Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis.
    Jachs M, Hartl L, Simbrunner B, Bauer D, Paternostro R, Balcar L, Hofer B, Pfisterer N, Schwarz M, Scheiner B, Stättermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T.
    Clin Gastroenterol Hepatol; 2023 Aug 15; 21(9):2318-2326.e7. PubMed ID: 35842118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.